<DOC>
	<DOC>NCT02271971</DOC>
	<brief_summary>The purpose of this study is to determine whether supplementation with oral vitamin D (cholecalciferol) improves metabolic parameters in patients with moderate to severe psoriasis.</brief_summary>
	<brief_title>Effect of Vitamin D Supplementation on Metabolic Parameters of Patients With Psoriasis</brief_title>
	<detailed_description />
	<mesh_term>Psoriasis</mesh_term>
	<mesh_term>Metabolic Syndrome X</mesh_term>
	<mesh_term>Vitamin D Deficiency</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<mesh_term>Cholecalciferol</mesh_term>
	<criteria>Clinical diagnosis of moderate to severe psoriasis. Being treated with methotrexate with stable doses for al least 1 month. Phototherapy within the past 2 months. History of psoriatic arthritis, rheumatoid arthritis, type 1 diabetes mellitus or inflammatory bowel disease. Use of vitamin d supplements or fish oil supplements in the past 2 months. Use of hypolipidemic drugs, hypoglycemic drugs, glucose sensitizers, oral corticosteroids, orlistat, cholestyramine, phenobarbital or phenytoin within the past 2 months. Pregnancy or lactation.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>Psoriasis</keyword>
	<keyword>Vitamin D</keyword>
	<keyword>Metabolic syndrome</keyword>
	<keyword>Insulin resistance</keyword>
	<keyword>Cholesterol</keyword>
	<keyword>Methotrexate</keyword>
	<keyword>Dyslipidemia</keyword>
	<keyword>PASI</keyword>
	<keyword>Psoriasis Area Severity Index</keyword>
</DOC>